APO Research
Talk to an analyst

APO RESEARCH · REPORT

Surgical Hemostatic Agents

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Surgical Hemostatic Agents Industry Growth and Trends Forecast to 2032

19 December 2025102 pages

Choose your research edition.

Industry ResearchSurgical Hemostatic Agents Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Surgical Hemostatic Agents Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Surgical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Surgical Hemostatic Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Surgical Hemostatic Agents Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Surgical Hemostatic Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Surgical Hemostatic Agents include J&J, Advance Medical Solution, B Braun, BD, CryoLife, CSL Behring, Equimedical, Ferrosan Medical Devices and Gelita, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Surgical Hemostatic Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Surgical Hemostatic Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Surgical Hemostatic Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Surgical Hemostatic Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Surgical Hemostatic Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Surgical Hemostatic Agents Market by Company

J&J

Advance Medical Solution

B Braun

BD

CryoLife

CSL Behring

Equimedical

Ferrosan Medical Devices

Gelita

Marine Polymer

Z-Medica

Baxter

Pfizer

Medtronic

Surgical Hemostatic Agents Segment by Type

Gelation Hemostats

Combination Hemostats

Others

Surgical Hemostatic Agents Segment by Application

Hospitals

Surgical Centers

Other

Surgical Hemostatic Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surgical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Surgical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surgical Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Surgical Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Surgical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gelation Hemostats Table 2. Major Company of Combination Hemostats Table 3. Major Company of Others Table 4. Global Surgical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 6. Global Surgical Hemostatic Agents Sales Market Share in Volume by Type (2021-2026) Table 7. Global Surgical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 8. Global Surgical Hemostatic Agents Sales Market Share in Value by Type (2021-2026) Table 9. Global Surgical Hemostatic Agents Price by Type (2021-2026) & (US$/Unit) Table 10. Global Surgical Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 11. Global Surgical Hemostatic Agents Sales Market Share in Volume by Type (2027-2032) Table 12. Global Surgical Hemostatic Agents Sales by Type (2027-2032) & (US$ Million) Table 13. Global Surgical Hemostatic Agents Sales Market Share in Value by Type (2027-2032) Table 14. Global Surgical Hemostatic Agents Price by Type (2027-2032) & (US$/Unit) Table 15. North America Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 16. North America Surgical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 18. Europe Surgical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Surgical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 22. Latin America Surgical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Surgical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 25. Surgical Hemostatic Agents Industry Trends Table 26. Surgical Hemostatic Agents Industry Drivers Table 27. Surgical Hemostatic Agents Industry Opportunities and Challenges Table 28. Surgical Hemostatic Agents Industry Restraints Table 29. Global Surgical Hemostatic Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Surgical Hemostatic Agents Revenue Market Share by Company (2021-2026) Table 31. Global Surgical Hemostatic Agents Sales by Company (2021-2026) & (K Units) Table 32. Global Surgical Hemostatic Agents Sales Share by Company (2021-2026) Table 33. Global Surgical Hemostatic Agents Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Surgical Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Surgical Hemostatic Agents Major Company Production Sites and Headquarters Table 36. Global Surgical Hemostatic Agents Company, Product Type & Application Table 37. Global Surgical Hemostatic Agents Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Surgical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Surgical Hemostatic Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Surgical Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 42. Global Surgical Hemostatic Agents Sales Market Share in Volume by Region (2021-2026) Table 43. Global Surgical Hemostatic Agents Sales by Region (2021-2026) & (US$ Million) Table 44. Global Surgical Hemostatic Agents Sales Market Share in Value by Region (2021-2026) Table 45. Global Surgical Hemostatic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Surgical Hemostatic Agents Sales by Region (2027-2032) & (K Units) Table 47. Global Surgical Hemostatic Agents Sales Market Share in Volume by Region (2027-2032) Table 48. Global Surgical Hemostatic Agents Sales by Region (2027-2032) & (US$ Million) Table 49. Global Surgical Hemostatic Agents Sales Market Share in Value by Region (2027-2032) Table 50. Global Surgical Hemostatic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Surgical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 53. Global Surgical Hemostatic Agents Sales Market Share in Volume by Application (2021-2026) Table 54. Global Surgical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 55. Global Surgical Hemostatic Agents Sales Market Share in Value by Application (2021-2026) Table 56. Global Surgical Hemostatic Agents Price by Application (2021-2026) & (US$/Unit) Table 57. Global Surgical Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 58. Global Surgical Hemostatic Agents Sales Market Share in Volume by Application (2027-2032) Table 59. Global Surgical Hemostatic Agents Sales by Application (2027-2032) & (US$ Million) Table 60. Global Surgical Hemostatic Agents Sales Market Share in Value by Application (2027-2032) Table 61. Global Surgical Hemostatic Agents Price by Application (2027-2032) & (US$/Unit) Table 62. North America Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 63. North America Surgical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 65. Europe Surgical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Surgical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 69. Latin America Surgical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Surgical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 72. J&J Company Information Table 73. J&J Business Overview Table 74. J&J Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. J&J Surgical Hemostatic Agents Product Portfolio Table 76. J&J Recent Development Table 77. Advance Medical Solution Company Information Table 78. Advance Medical Solution Business Overview Table 79. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Advance Medical Solution Surgical Hemostatic Agents Product Portfolio Table 81. Advance Medical Solution Recent Development Table 82. B Braun Company Information Table 83. B Braun Business Overview Table 84. B Braun Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. B Braun Surgical Hemostatic Agents Product Portfolio Table 86. B Braun Recent Development Table 87. BD Company Information Table 88. BD Business Overview Table 89. BD Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. BD Surgical Hemostatic Agents Product Portfolio Table 91. BD Recent Development Table 92. CryoLife Company Information Table 93. CryoLife Business Overview Table 94. CryoLife Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. CryoLife Surgical Hemostatic Agents Product Portfolio Table 96. CryoLife Recent Development Table 97. CSL Behring Company Information Table 98. CSL Behring Business Overview Table 99. CSL Behring Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. CSL Behring Surgical Hemostatic Agents Product Portfolio Table 101. CSL Behring Recent Development Table 102. Equimedical Company Information Table 103. Equimedical Business Overview Table 104. Equimedical Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Equimedical Surgical Hemostatic Agents Product Portfolio Table 106. Equimedical Recent Development Table 107. Ferrosan Medical Devices Company Information Table 108. Ferrosan Medical Devices Business Overview Table 109. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio Table 111. Ferrosan Medical Devices Recent Development Table 112. Gelita Company Information Table 113. Gelita Business Overview Table 114. Gelita Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Gelita Surgical Hemostatic Agents Product Portfolio Table 116. Gelita Recent Development Table 117. Marine Polymer Company Information Table 118. Marine Polymer Business Overview Table 119. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Marine Polymer Surgical Hemostatic Agents Product Portfolio Table 121. Marine Polymer Recent Development Table 122. Z-Medica Company Information Table 123. Z-Medica Business Overview Table 124. Z-Medica Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Z-Medica Surgical Hemostatic Agents Product Portfolio Table 126. Z-Medica Recent Development Table 127. Baxter Company Information Table 128. Baxter Business Overview Table 129. Baxter Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Baxter Surgical Hemostatic Agents Product Portfolio Table 131. Baxter Recent Development Table 132. Pfizer Company Information Table 133. Pfizer Business Overview Table 134. Pfizer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Pfizer Surgical Hemostatic Agents Product Portfolio Table 136. Pfizer Recent Development Table 137. Medtronic Company Information Table 138. Medtronic Business Overview Table 139. Medtronic Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Medtronic Surgical Hemostatic Agents Product Portfolio Table 141. Medtronic Recent Development Table 142. North America Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 144. North America Surgical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 145. North America Surgical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Surgical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 147. North America Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Surgical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Surgical Hemostatic Agents Market Share by Country (2021-2026) Table 150. North America Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Surgical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 152. Europe Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 154. Europe Surgical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 155. Europe Surgical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Surgical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Surgical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Surgical Hemostatic Agents Market Share by Country (2021-2026) Table 160. Europe Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Surgical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Surgical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Surgical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Surgical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Surgical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Surgical Hemostatic Agents Market Share by Country (2021-2026) Table 170. Asia-Pacific Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Surgical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 172. Latin America Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 174. Latin America Surgical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 175. Latin America Surgical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Surgical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Surgical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Surgical Hemostatic Agents Market Share by Country (2021-2026) Table 180. Latin America Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Surgical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Surgical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Surgical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Surgical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Surgical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Surgical Hemostatic Agents Market Share by Country (2021-2026) Table 190. Middle East and Africa Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Surgical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Surgical Hemostatic Agents Distributors List Table 195. Surgical Hemostatic Agents Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Surgical Hemostatic Agents Image Figure 2. Global Surgical Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Surgical Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Surgical Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Gelation Hemostats Image Figure 6. Global Gelation Hemostats Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Hemostats Image Figure 8. Global Combination Hemostats Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Surgical Hemostatic Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Surgical Hemostatic Agents Market Share by Type 2025 VS 2032 Figure 13. North America Surgical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 14. North America Surgical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 15. Europe Surgical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 16. Europe Surgical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Surgical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Surgical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 19. Latin America Surgical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Surgical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Surgical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Surgical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Surgical Hemostatic Agents Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Surgical Centers Image Figure 28. Global Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Surgical Hemostatic Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Surgical Hemostatic Agents Market Share by Application 2025 VS 2032 Figure 33. North America Surgical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 34. North America Surgical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 35. Europe Surgical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 36. Europe Surgical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Surgical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Surgical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 39. Latin America Surgical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Surgical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Surgical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Surgical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 43. North America Surgical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Surgical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Surgical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Surgical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Surgical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Surgical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Surgical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Surgical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Surgical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Surgical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Surgical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Surgical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Surgical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Surgical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Surgical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Surgical Hemostatic Agents Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Surgical Hemostatic Agents Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Hemostats
  • Combination Hemostats
  • Others
Applications
  • Hospitals
  • Surgical Centers
  • Other
Companies covered
  • J&J
  • Advance Medical Solution
  • B Braun
  • BD
  • CryoLife
  • CSL Behring
  • Equimedical
  • Ferrosan Medical Devices
  • Gelita
  • Marine Polymer
  • Z-Medica
  • Baxter
  • Pfizer
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Surgical Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Surgical Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Surgical Hemostatic Agents Market by Type
  6. 1.3.1 Gelation Hemostats
  7. 1.3.2 Combination Hemostats
  8. 1.3.3 Others
  9. 1.4 Global Surgical Hemostatic Agents Market Size by Type
  10. 1.4.1 Global Surgical Hemostatic Agents Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Surgical Hemostatic Agents Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Surgical Hemostatic Agents Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Surgical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Surgical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Surgical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Surgical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Surgical Hemostatic Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Surgical Hemostatic Agents Industry Trends
  2. 2.2 Surgical Hemostatic Agents Industry Drivers
  3. 2.3 Surgical Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Surgical Hemostatic Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Surgical Hemostatic Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Surgical Hemostatic Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Surgical Hemostatic Agents Price (2021-2026)
  4. 3.4 Global Surgical Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Surgical Hemostatic Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Surgical Hemostatic Agents Company, Product Type & Application
  7. 3.7 Global Surgical Hemostatic Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Surgical Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Surgical Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Surgical Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Surgical Hemostatic Agents Regional Status and Outlook
  1. 4.1 Global Surgical Hemostatic Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Surgical Hemostatic Agents Historic Market Size by Region
  3. 4.2.1 Global Surgical Hemostatic Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Surgical Hemostatic Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Surgical Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Surgical Hemostatic Agents Forecasted Market Size by Region
  7. 4.3.1 Global Surgical Hemostatic Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Surgical Hemostatic Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Surgical Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Surgical Hemostatic Agents by Application
  1. 5.1 Surgical Hemostatic Agents Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Other
  5. 5.2 Global Surgical Hemostatic Agents Market Size by Application
  6. 5.2.1 Global Surgical Hemostatic Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Surgical Hemostatic Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Surgical Hemostatic Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Surgical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Surgical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Surgical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Surgical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Surgical Hemostatic Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 J&J
  2. 6.1.1 J&J Company Information
  3. 6.1.2 J&J Business Overview
  4. 6.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 J&J Surgical Hemostatic Agents Product Portfolio
  6. 6.1.5 J&J Recent Developments
  7. 6.2 Advance Medical Solution
  8. 6.2.1 Advance Medical Solution Company Information
  9. 6.2.2 Advance Medical Solution Business Overview
  10. 6.2.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Advance Medical Solution Surgical Hemostatic Agents Product Portfolio
  12. 6.2.5 Advance Medical Solution Recent Developments
  13. 6.3 B Braun
  14. 6.3.1 B Braun Company Information
  15. 6.3.2 B Braun Business Overview
  16. 6.3.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 B Braun Surgical Hemostatic Agents Product Portfolio
  18. 6.3.5 B Braun Recent Developments
  19. 6.4 BD
  20. 6.4.1 BD Company Information
  21. 6.4.2 BD Business Overview
  22. 6.4.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BD Surgical Hemostatic Agents Product Portfolio
  24. 6.4.5 BD Recent Developments
  25. 6.5 CryoLife
  26. 6.5.1 CryoLife Company Information
  27. 6.5.2 CryoLife Business Overview
  28. 6.5.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CryoLife Surgical Hemostatic Agents Product Portfolio
  30. 6.5.5 CryoLife Recent Developments
  31. 6.6 CSL Behring
  32. 6.6.1 CSL Behring Company Information
  33. 6.6.2 CSL Behring Business Overview
  34. 6.6.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSL Behring Surgical Hemostatic Agents Product Portfolio
  36. 6.6.5 CSL Behring Recent Developments
  37. 6.7 Equimedical
  38. 6.7.1 Equimedical Company Information
  39. 6.7.2 Equimedical Business Overview
  40. 6.7.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Equimedical Surgical Hemostatic Agents Product Portfolio
  42. 6.7.5 Equimedical Recent Developments
  43. 6.8 Ferrosan Medical Devices
  44. 6.8.1 Ferrosan Medical Devices Company Information
  45. 6.8.2 Ferrosan Medical Devices Business Overview
  46. 6.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio
  48. 6.8.5 Ferrosan Medical Devices Recent Developments
  49. 6.9 Gelita
  50. 6.9.1 Gelita Company Information
  51. 6.9.2 Gelita Business Overview
  52. 6.9.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Gelita Surgical Hemostatic Agents Product Portfolio
  54. 6.9.5 Gelita Recent Developments
  55. 6.10 Marine Polymer
  56. 6.10.1 Marine Polymer Company Information
  57. 6.10.2 Marine Polymer Business Overview
  58. 6.10.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Marine Polymer Surgical Hemostatic Agents Product Portfolio
  60. 6.10.5 Marine Polymer Recent Developments
  61. 6.11 Z-Medica
  62. 6.11.1 Z-Medica Company Information
  63. 6.11.2 Z-Medica Business Overview
  64. 6.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Z-Medica Surgical Hemostatic Agents Product Portfolio
  66. 6.11.5 Z-Medica Recent Developments
  67. 6.12 Baxter
  68. 6.12.1 Baxter Company Information
  69. 6.12.2 Baxter Business Overview
  70. 6.12.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Baxter Surgical Hemostatic Agents Product Portfolio
  72. 6.12.5 Baxter Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Surgical Hemostatic Agents Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Medtronic
  80. 6.14.1 Medtronic Company Information
  81. 6.14.2 Medtronic Business Overview
  82. 6.14.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Medtronic Surgical Hemostatic Agents Product Portfolio
  84. 6.14.5 Medtronic Recent Developments
7 North America by Country
  1. 7.1 North America Surgical Hemostatic Agents Sales by Country
  2. 7.1.1 North America Surgical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Surgical Hemostatic Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Surgical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Surgical Hemostatic Agents Market Size by Country
  6. 7.2.1 North America Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Surgical Hemostatic Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Surgical Hemostatic Agents Sales by Country
  2. 8.1.1 Europe Surgical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Surgical Hemostatic Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Surgical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Surgical Hemostatic Agents Market Size by Country
  6. 8.2.1 Europe Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Surgical Hemostatic Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Surgical Hemostatic Agents Sales by Country
  2. 9.1.1 Asia-Pacific Surgical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Surgical Hemostatic Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Surgical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Surgical Hemostatic Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Surgical Hemostatic Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Surgical Hemostatic Agents Sales by Country
  2. 10.1.1 South America Surgical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Surgical Hemostatic Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Surgical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Surgical Hemostatic Agents Market Size by Country
  6. 10.2.1 South America Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Surgical Hemostatic Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Surgical Hemostatic Agents Sales by Country
  2. 11.1.1 Middle East and Africa Surgical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Surgical Hemostatic Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Surgical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Surgical Hemostatic Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Surgical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Surgical Hemostatic Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Surgical Hemostatic Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Surgical Hemostatic Agents Value Chain Analysis
  2. 12.1.1 Surgical Hemostatic Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Surgical Hemostatic Agents Production Mode & Process
  7. 12.2 Surgical Hemostatic Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Surgical Hemostatic Agents Distributors
  10. 12.2.3 Surgical Hemostatic Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst